Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2008
03/25/2008US7348176 Chamber with adjustable volume for cell culture and organ assist
03/25/2008US7348163 screening compounds for modulation of gamma -aminobutyric acid (GABA-B subtype) receptor transcription; comprises firefly luciferase as reporter gene
03/25/2008US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and
03/25/2008US7348156 7B2 knockout transgenic animals as models of endocrine disease
03/25/2008US7348134 Cell-free system for translation and formation of HTLV lymphadenopathy associated viral coat proteins; viricides; drug screening
03/25/2008US7348004 Immunoglobulin chimeric monomer-dimer hybrids
03/25/2008US7347999 use in bone marrow transplantation, into bone marrow cavity or into extraskeletal sites, such as the kidney capsule, muscles, liver, abdominal wall; treatment of diseases affecting the stromal microenvironment that controls hematopoiesis
03/25/2008US7347998 Method of delivering therapeutic agents to site of tissue injury
03/25/2008US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
03/25/2008US7347876 Method for expansion of epithelial stem cells
03/25/2008US7347872 Implant comprising a pair of bone anchors joined at their proximal ends by at least one support filament coated by a matrix layer of thickness sufficient to allow for colonization by a cell; tissue engineering
03/25/2008CA2599771A1 Method for preparing agglutinatable platelet fragments and the use thereof
03/25/2008CA2446938C Cryopreservation system with controlled dendritic freezing front velocity
03/25/2008CA2348776C High fidelity thermostable ligase and uses thereof
03/25/2008CA2347242C Method for vitrification of a biological specimen
03/25/2008CA2285382C Neocartilage and methods of use
03/25/2008CA2254871C Purification of biologically active peptides from milk
03/25/2008CA2195795C Kin equivalent comprising langerhans cells
03/25/2008CA2164642C Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
03/25/2008CA2151127C Methods for stable transformation of wheat
03/25/2008CA2115579C Ryegrass pollen allergen
03/25/2008CA2084079C Glycogen biosynthetic enzymes in plants
03/20/2008WO2008033545A2 Triphenylphosphine oxide derivatives and uses thereof
03/20/2008WO2008033517A2 Cell culture improvements
03/20/2008WO2008033469A1 Methods for producing embryonic stem cells from parthenogenetic embryos
03/20/2008WO2008033393A2 Isolation, expansion and uses of tumor stem cells
03/20/2008WO2008033375A2 Long lasting drug formulations
03/20/2008WO2008033032A2 Method and device for micropropagation of plants
03/20/2008WO2008032874A1 Method for screening for agent capable of controlling in vivo hypoxia-responsive system
03/20/2008WO2008032053A1 Fhr-4a splicing variants
03/20/2008WO2008031957A2 Method for extracting and selecting cells
03/20/2008WO2008031910A2 Experimental models for non-microcytic lung cancer metastasis to bone
03/20/2008WO2008031767A1 Cell culture of keratinocytes under non-differentiating conditions
03/20/2008WO2008031588A1 Differentiating of stem cells
03/20/2008WO2008031451A1 A post-natal periodontal-derived neural stem cell
03/20/2008WO2008031448A1 Preparation of autologous non-hematopoietic progenitor stem cells, method of preparation and use thereof
03/20/2008WO2008016958A3 Reproductive cell media compositions and methods for improving fertility
03/20/2008WO2008009565A3 Method for screening an enhancer or a masker of salty taste
03/20/2008WO2008008857A3 Thiolated macromolecules and methods of making and using thereof
03/20/2008WO2007149554A3 Methods for restoring neural function
03/20/2008WO2007146811A3 Assessment of cellular composition and fractional viability and uses thereof
03/20/2008WO2007141043A3 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma
03/20/2008WO2007136673A3 Treatment of disc degenerative disease and compositions for same
03/20/2008WO2007127254A3 Compositions and methods for generating transgenic animals
03/20/2008WO2007098742A3 Prevascularized tissue transplant constructs for the reconstruction of a human or animal organ
03/20/2008WO2006076741A3 Canine 5-hydroxytryptamine 2a and 2b receptor materials and thier use
03/20/2008WO2001025398A3 Process for inducing functional tolerance to gene transfer products
03/20/2008US20080072354 Nucleic acid molecules and other molecules associated with plants
03/20/2008US20080072352 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
03/20/2008US20080072351 Fatty Acid Desaturases and Uses Thereof
03/20/2008US20080072350 Polynucleotides encoding plant prenyl proteases
03/20/2008US20080072349 Rubisco Activase with Increased Thermostability and Methods of Use Thereof
03/20/2008US20080072347 Transcription factor stress-related proteins and methods of use in plants
03/20/2008US20080072346 Wheat variety 26r87
03/20/2008US20080072345 Transgenic seeds for use in generating herbicide, insect and disease resistant crop plants with waxy starch
03/20/2008US20080072344 Highly Transformable Elite Inbred Line-PHWWE
03/20/2008US20080072343 Transgenic seeds for propagation of herbicide, insect, drought and disease resistant maize plants with enhanced culturability, phosphorus, antioxidants, carbohydrate and fatty acids metabolism
03/20/2008US20080072342 Lettuce cultivar green thunder
03/20/2008US20080072340 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics
03/20/2008US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent
03/20/2008US20080071065 Fibroblast Growth Factor-Like Polypeptides
03/20/2008US20080070963 Compositions and methods for promoting neural regeneration
03/20/2008US20080070957 p-(2-alkoxy-2-acylethyl)biphenyl compounds; 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases,; lipid metabolism diseases; Peroxisome Proliferator-Activated Receptor modulator
03/20/2008US20080070954 inhibitors of histone deacetylase; antiproliferative; anticancer; 8-[3-(4-methylbenzenesulfonyl)-ureido])-octanoic acid hydroxyamide
03/20/2008US20080070932 unexpectedly potent antagonists of A2a adenosine receptor; Parkinson's; neurodegenerative diseases; 2-furan-2-yl-N5-[1-(5-methyl-isoxazol-3-ylmethyl)-pyrrolidin-2-ylmethyl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-diamine
03/20/2008US20080070865 Inhibiting a taste modulating protein; used in pharmaceutical, food, and other products to inhibit certain taste functions and perceptions; side effects reduction
03/20/2008US20080070859 Treats neoplastic disorders, infections from fungal or fungal-like organisms and other parasites
03/20/2008US20080070854 Conserved Hbv and Hcv Sequences Useful for Gene Silencing
03/20/2008US20080070840 Polypeptides or peptides modified to include at least one antibody Fc region and, optionally, one or more water soluble polymers; have ability to stimulate in vivo and in vitro production of platelets, and/or megakaryocytopoietic activity, i.e., the ability to stimulate production of platelet precursors
03/20/2008US20080070837 Variants of human bone morphogenetic proteins and other cysteine knot cytokine proteins with improved properties, including increased expression yield, expression in absence of a pro-domain, increased solubility, increased specific activity, altered receptor, co-receptor, inhibitor specificity
03/20/2008US20080070835 Hla-Dr-Binding Antigen Peptide Derived From Wt1
03/20/2008US20080070831 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications
03/20/2008US20080070830 Homing of cells to myocardium
03/20/2008US20080070829 Family of pesticidal proteins and methods for their use
03/20/2008US20080070306 Genetically modified plant comprising transcription factor sequences for enhancing efficacy of exogenous gene expression
03/20/2008US20080070305 Inhibition of expression of a target gene
03/20/2008US20080070304 Self-Assembling Cell Aggregates and Methods of Making Engineered Tissue Using the Same
03/20/2008US20080070303 Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
03/20/2008US20080070302 Method for treatment of cellular materials with sugars prior to preservation
03/20/2008US20080070301 Preparing xenograft of pig pancreatic tissue for use in prevention and treatment of diabetic disorders; antidiabetic agents
03/20/2008US20080070300 Human chemotactic cytokine
03/20/2008US20080070299 Synthetic nucleic acid molecule compositions and methods of preparation
03/20/2008US20080070298 Promoter of Synoviolin Gene
03/20/2008US20080070291 Nucleotide sequences coding chlorophyllase for use in preparation of paper products, detergents and foods
03/20/2008US20080070287 Transforming the Bacillus cell with a heterologous nucleotide sequence encoding a lipid acyltransferase, expressing the lipid acyltransferase in the cell, transforming the Bacillus licheniformis cell with a heterologous nucleotide sequence, expressing the lipid acyltransferase
03/20/2008US20080070286 Dna Participating in Hydroxylation of Macrolide Compound
03/20/2008US20080070276 Transcriptional Termination of Transgene Expression Using Host Genomic Terminators
03/20/2008US20080070268 Differential expression profiling analysis of cell culture phenotypes and the uses thereof
03/20/2008US20080070267 changing the pattern of Ca2+ spike activity of the neuron; treating psychological disorder using electrical or chemical stimulants, or antagonist; altering neurotransmitter expression; autism, anxiety disorder, post-traumatic stress disorder, depression, bipolar disorder and schizophrenia
03/20/2008US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders
03/20/2008US20080070256 Non-Human Animal Models for B-cell Non-Hodgkin's Lymphoma and Uses Thereof
03/20/2008US20080070249 Peroxisome proliferator activator gamma coactivator-1 alpha (PGC-1 alpha ) for use as modulator of glucose transport; antidiabetic agents
03/20/2008US20080070246 Recombinant protein and method of screening for agents that modulate polypeptide aggregation
03/20/2008US20080070237 Npas3 Mutant Mice and Uses for Screening and Testing Therapies for Schizophrenia and Related Neurological Disorders
03/20/2008US20080069941 Animals for Conserving N-3 Highly Unsaturated Fatty Acids
03/20/2008US20080069900 Combination chemotherapy compositions and methods
03/20/2008US20080069895 Mammalian membrane ; dry flat or tube; shaping to fit body structure; isolation, decellularization
03/20/2008US20080069866 Immunotherapeutic methods and compositions
03/20/2008US20080069846 Gene coding, gene expression, purification; used as detergents, cosmetics, leather processing, softening for food, meats, animal feeds
03/20/2008US20080069823 Attenuation of Reperfusion Injury